Interv Akut Kardiol. 2019;18(3):162-164

Using drug-eluting balloons in coronary interventions from the perspective of the BASKET-SMALL 2 trial

Tomáš Kovárník1, Karel Kopřiva2
1 II. interní klinika kardiologie a angiologie VFN a 1. LF UK v Praze
2 Kardiologické oddělení Nemocnice Na Homolce, Praha

The authors present a review of the current options of using paclitaxel-coated drug-eluting balloons (DEBs). They discuss the options
of treatment with this instrumentarium in managing in-stent restenosis as well as de novo lesions. Main emphasis is placed
on the recently published BASKET-SMALL 2 trial. Also discussed is the role of sirolimus-coated DEBs.

Keywords: coronary stenoses, drug-eluting balloons, drug-eluting stents

Received: October 10, 2019; Revised: November 3, 2019; Accepted: November 4, 2019; Prepublished online: November 4, 2019; Published: November 1, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kovárník T, Kopřiva K. Using drug-eluting balloons in coronary interventions from the perspective of the BASKET-SMALL 2 trial. Interv Akut Kardiol. 2019;18(3):162-164.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. European Heart Journal 2018; 00: 1-96. Go to original source...
    2. Katz G, Harchandani B, Shah B. Drug-eluting stents: the past, present, and future. Curr Atheroscler Rep. 2015; 17: 485. Go to original source... Go to PubMed...
    3. Unverdorben M, Kleber FX, Heuer H, et al. Treatment of small coronary arteries with a paclitaxel-coated balloon catheter. Clin Res Cardiol. 2010; 99: 165-74. Go to original source... Go to PubMed...
    4. Gao L, Chen YD. Application of drug-coated balloon in coronary artery intervention: challenges and opportunities. J Geriatr Cardiol. 2016; 13: 906-13. Go to PubMed...
    5. Fro?hlich GM, Lansky AJ, Ko DT, et al. Drug eluting balloons for de novocoronary lesions - a systematic review and meta-analysis. BMC Med. 2013; 11: 123. Go to original source... Go to PubMed...
    6. Jackson D, Tong D, Layland J. A review of the coronary applications of the drug coated balloon. Int J Cardiol. 2017; 226: 77-86. Go to original source... Go to PubMed...
    7. Scheller B, Hehrlein C, Bocksch W, et al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. New England journal of medicine 2006; 355: 2113-24. Go to original source... Go to PubMed...
    8. Pleva L, Kukla P, Kusnierova P, et al. Comparison of the Efficacy of Paclitaxel-Eluting Balloon Catheters and Everolimus-Eluting Stents in the Treatment of Coronary In-Stent Restenosis The Treatment of In-Stent Restenosis Study. Circ Cardiovasc Interv. 2016; 9: e003316. Go to original source... Go to PubMed...
    9. Liu L, Liu B, Ren J, et al. Comparison of drug-eluting balloon versus drug-eluting stent for treatment of coronary artery disease: a meta-analysis of randomized controlled trialsů. BMC Cardiovascular Disorders 2018; 18: 46. Go to original source... Go to PubMed...
    10. Rittger H, Brachmann J, Sinha AM, et al. A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: The PEPCAD - DES study. J Am Coll Cardiol 2012; 59: 1377-1382. Go to original source... Go to PubMed...
    11. Baan J Jr, Claessen BE, Dijk KB, et al. A randomized comparison of paclitaxel-eluting balloon versus everolimus-eluting stent for the treatment of any in-stent restenosis: The DARE trial. JACC Cardiovasc Interv 2018; 11: 275-283. Go to original source... Go to PubMed...
    12. Jeger RV, Farah A, Ohlow MA, et al. Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial. Lancet 2018; 392: 849-856. Go to original source... Go to PubMed...
    13. Cortese B, Micheli A, Picchi A, et al. Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO study. Heart 2010; 96: 1291-96. Go to original source... Go to PubMed...
    14. Latib A, Colombo A, Castriota F, et al. A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study. J Am Coll Cardiol 2012; 60: 2473-80. Go to original source... Go to PubMed...
    15. Unverdorben M, Kleber F, Heuer H, et al. Treatment of small coronary arteries with a paclitaxel-coated balloon catheter. Clin Res Cardiol 2010; 99: 165-74. Go to original source... Go to PubMed...
    16. Megaly M, Rofael M, Saad M, et al. Outcomes with drug-coated balloons in small-vessel coronary artery disease. J. Invasive Cardiol. 2018; 30: 393-399. Go to original source...
    17. Stella PR, Belkacemi A, Dubois C, et al. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial. Catheterization and cardiovascular interventions 2012; 80: 1138-46. Go to original source... Go to PubMed...
    18. Kovarnik T, Mintz GS, Sonka M. The late stent malapposition develops also after paclitaxel balloon predilatation before bare-metal stent implantation:case description. Eur Heart J. 2011; 2: 1432. Go to original source... Go to PubMed...
    19. Stone GW, Ellis SG, Colombo A, et al. Long-term safety and efficacy of paclitaxel-eluting stents final 5-year analysis from the TAXUS clinical trial program. JACC Cardiovasc Interv. 2011; 4: 530-542. Go to original source... Go to PubMed...
    20. Gongora CA, Shibuya M, Wessler JD, et al. Impact of paclitaxel dose on tissue pharmacoki - netics and vascular healing: a comparative drug-coated balloon study in the familial hypercholesterolemic swine model of superficial femoral in-stent restenosis. JACC Cardiovasc Interv. 2015; 8: 1115-1123. Go to original source... Go to PubMed...
    21. Granada JF, Stenoien M, Buszman PP, et al. Mechanisms of tissue uptake and retention of paclitaxel-coated balloons: impact on neointimal proliferation and healing. Open Heart. 2014; 1: e000117. Go to original source... Go to PubMed...
    22. Levin AD, VCukmirovic N, Hwang CW, et al. Specific bindings to intracelullar proteins determines arterial transport properties for rapamycin and paclitaxel. Proceedings of the National Academy of Sciences of the United States of America 2004; 101: 9463-7. Go to original source... Go to PubMed...

    Return to the content


    Interventional Cardiology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.